Dermata Therapeutics Inc. Skyrocketed
Dermata Therapeutics Inc. (DRMA:NASDAQ) soared at $2.67, representing a gain of 105.4%. On Wed, Jul 24, 2024, DRMA:NASDAQ hit a New 2-Week High of $2.67. The stock appeared on our News Catalysts scanner on Wed, Jul 17, 2024 at 10:05 AM in the 'BIOTECH' category. From Wed, Jul 10, 2024, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Jul 24, 2024 at $5 with a volume of 65M+.
About Dermata Therapeutics Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 105.38%
- Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ), 89.55%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Selina Hospitality PLC (SLNA:NASDAQ), 75.77%
- QXO Inc Com Par Value $0.00001 (New) (QXO:NASDAQ), 56.32%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- Sangamo Therapeutics, Inc. (SGMO:NASDAQ), 39.55%
- SCWorx Corp. (WORX:NASDAQ), 39.13%
- KORE Group Holdings Inc. (KORE:NYSE), 33.48%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 31.77%